Christopher Redfern - Publications

Affiliations: 
 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Khatib T, Whiting A, Chisholm DR, Redfern C, Müller B, McCaffery P. A Bioluminescence Reporter Assay for Retinoic Acid Control of Translation of the GluR1 Subunit of the AMPA Glutamate Receptor. Molecular Neurobiology. PMID 30972628 DOI: 10.1007/s12035-019-1571-9  0.324
2019 Chisholm DR, Tomlinson CWE, Zhou GL, Holden C, Affleck V, Lamb R, Newling K, Ashton P, Valentine R, Redfern C, Erostyák J, Makkai G, Ambler CA, Whiting A, Pohl E. Fluorescent retinoic acid analogues as probes for biochemical and intracellular characterization of retinoid signaling pathways. Acs Chemical Biology. PMID 30707838 DOI: 10.1021/Acschembio.8B00916  0.303
2018 Haffez H, Chisholm DR, Tatum NJ, Valentine R, Redfern C, Pohl E, Whiting A, Przyborski S. Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids. Bioorganic & Medicinal Chemistry. PMID 29439915 DOI: 10.1016/J.Bmc.2018.02.002  0.316
2017 Haffez H, Chisholm DR, Valentine R, Pohl E, Redfern C, Whiting A. The molecular basis of the interactions between synthetic retinoic acid analogues and the retinoic acid receptors. Medchemcomm. 8: 578-592. PMID 30108774 DOI: 10.1039/C6Md00680A  0.31
2017 Haffez H, Khatib T, McCaffery P, Przyborski S, Redfern C, Whiting A. Neurogenesis in Response to Synthetic Retinoids at Different Temporal Scales. Molecular Neurobiology. PMID 28244006 DOI: 10.1007/s12035-017-0440-7  0.338
2011 Nicholson L, Evans C, Matheson EC, Minto L, Keilty C, Schwab C, Harrison CJ, Hall AG, Redfern C, Whetton A, Irving J. Quantitative Proteomic Analysis Reveals Maturation As a Mechanism Underlying Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia and PAX5 As a Re-Sensitising Therapeutic Target Blood. 118: 1411-1411. DOI: 10.1182/Blood.V118.21.1411.1411  0.327
2009 Nicholson L, Evans C, Matheson E, Minto L, Keilty C, Hall A, Redfern C, Whetton A, Irving J. Quantitative Proteomic Analysis Implicates An Altered B-Cell Differentiation State as a Mechanism Underlying GC-Resistance in An Acute Lymphoblastic Leukaemia (ALL) Cell Line Model Blood. 114: 1736-1736. DOI: 10.1182/Blood.V114.22.1736.1736  0.335
2007 Armstrong JL, Taylor GA, Thomas HD, Boddy AV, Redfern CP, Veal GJ. Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo. British Journal of Cancer. 96: 1675-83. PMID 17486130 DOI: 10.1038/sj.bjc.6603779  0.301
2001 Lovat PE, Dobson M, Malcolm AJ, Pearson AD, Redfern CP. Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells. Medical and Pediatric Oncology. 36: 135-8. PMID 11464866 DOI: 10.1002/1096-911X(20010101)36:1<135::AID-MPO1032>3.0.CO;2-4  0.319
1995 Redfern C, Lovat P, Malcolm A, Pearson A. Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. European Journal of Cancer. 31: 486-494. PMID 7576951 DOI: 10.1016/0959-8049(95)00066-R  0.319
Show low-probability matches.